Reference
Iovino A, et al. Alemtuzumab in Covid era. Multiple Sclerosis and Related Disorders 51: 102908, Jun 2021. Available from: URL: http://www.elsevier.com/wps/find/journaldescription.cws_home/725776/description#description
Rights and permissions
About this article
Cite this article
Alemtuzumab/cladribine/natalizumab. Reactions Weekly 1884, 27 (2021). https://doi.org/10.1007/s40278-021-06348-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-021-06348-7